Old API Wind-down Ltd - Ordinary Shares ARLZQ

Reluctance to sell

[kuatolives]

This is probably one of those times where as soon as I open my mouth, the opposite will happen, but it's interesting today to see the selloff in pharma not really affecting ARLZ all that much.  With the FDA response now coming any day, people don't want to miss out on the expected rally. 

It's also interesting to see how the Concordia's and Valeants are hitting fresh 52 week lows (at least with Concordia) with concerns over inorganic growth and debt burdons. This FDA announcement might be coming at a really good time when investors are sensitive to the difference between organic and inorganic growth in the pharma sector.